WEST PHARMACEUTICAL SERVICES INC (WST) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for WEST PHARMACEUTICAL SERVICES INC (WST): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 56/100 — a percentile rank of WEST PHARMACEUTICAL SERVICES INC’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $25.7B |
| P / E | 45.5× |
| P / S | 7.7× |
| EV / EBITDA | 28.2× |
| Gross margin | 36.8% |
| Operating margin | 21.7% |
| Net margin | 17.0% |
| Return on equity | 18.9% |
| ROIC | 20.8% |
| Revenue growth | 12.4% |
| Debt / equity | 0.1× |
| Dividend yield | 0.2% |
Is WEST PHARMACEUTICAL SERVICES INC overvalued? P/E looks fair vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from WEST PHARMACEUTICAL SERVICES INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact